The Systolic Blood Pressure Intervention Trial (SPRINT) estimated the effect of intensive SBP treatment (target <120 mmHg) compared to standard (<140 mmHg) on the risk of cardiovascular events in adults aged 50+ years. Clinical trial participants may differ from an intervention's target population. We generalized the SPRINT results to U.
View Article and Find Full Text PDFResearch articles in the clinical and translational science literature commonly use quantitative data to inform evaluation of interventions, learn about the etiology of disease, or develop methods for diagnostic testing or risk prediction of future events. The peer review process must evaluate the methodology used therein, including use of quantitative statistical methods. In this manuscript, we provide guidance for peer reviewers tasked with assessing quantitative methodology, intended to complement guidelines and recommendations that exist for manuscript authors.
View Article and Find Full Text PDFObjective: Over the last few decades clinicians have become aware that cognitive impairment might be a major cause of disability, loss of employment and poor quality of life in patients suffering from multiple sclerosis [MS].The impact of disease modifying therapies [DMTs] on cognition is still a matter of debate. Theoretically, DMTs could exert a substantial beneficial effect by means of reducing neuroinflammation and brain atrophy, which are established correlates of cognitive dysfunction.
View Article and Find Full Text PDF